ZA978170B - Novel amino alcohol derivatives process for their manufacture and medical preparations containing these compounds - Google Patents

Novel amino alcohol derivatives process for their manufacture and medical preparations containing these compounds

Info

Publication number
ZA978170B
ZA978170B ZA978170A ZA978170A ZA978170B ZA 978170 B ZA978170 B ZA 978170B ZA 978170 A ZA978170 A ZA 978170A ZA 978170 A ZA978170 A ZA 978170A ZA 978170 B ZA978170 B ZA 978170B
Authority
ZA
South Africa
Prior art keywords
different
group
stand
radical
compounds
Prior art date
Application number
ZA978170A
Inventor
Walter-Gunar Friebe
Nikolaos Dimoudis
Use Michaelis
Bernhard Knipp
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of ZA978170B publication Critical patent/ZA978170B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/06—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having the hydroxy groups esterified by carboxylic acids having the esterifying carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to new amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds. The subject of the invention is medicaments having the general formula (I) wherein A can mean hydrogen, a group NR1R2, a group NR1(CH2)pNR3R4, a group (C=NH)NH2 or a pyridinyl radical, B and D can be identical or different and stand each for a binding, a C1 to C6-alkylene radical or a group NR5-C2-C6-alkylene, C can mean piperidindiyl or piperazindiyl, W and X are identical or different and stand each for a carbonyl group, Y and Z can be identical or different and stand each for a saturated or unsaturated hydrocarbon radical with 7-24 carbon atoms, R1 to R5 can be identical or different and stand each for hydrogen or a C1 to C6 alkyl radical, m stands for a whole number 0, 1, or 2 and if m = 2 both radicals C independently from another can also mean piperidindiyl and piperazindiyl, n and o can be identical or different and stand each for a whole number 2, 3 or 4 and p means a whole number from 2 to 6, as well as their physiologically compatible salts, with the proviso that no hydrazine derivatives are comprised and that m be not 0, when A means hydrogen or a group (C=NH)NH2 and B and D are identical or different and represent a binding or an alkylene radical.
ZA978170A 1996-09-12 1997-09-11 Novel amino alcohol derivatives process for their manufacture and medical preparations containing these compounds ZA978170B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19637043A DE19637043A1 (en) 1996-09-12 1996-09-12 Novel amino alcohol derivatives, processes for their preparation and medicaments and reagents containing these compounds

Publications (1)

Publication Number Publication Date
ZA978170B true ZA978170B (en) 1999-03-11

Family

ID=7805345

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA978170A ZA978170B (en) 1996-09-12 1997-09-11 Novel amino alcohol derivatives process for their manufacture and medical preparations containing these compounds

Country Status (12)

Country Link
EP (1) EP0927174B1 (en)
JP (1) JP4191251B2 (en)
KR (1) KR20000036063A (en)
CN (1) CN1087293C (en)
AT (1) ATE380798T1 (en)
AU (1) AU741636B2 (en)
BR (1) BR9712818A (en)
CA (1) CA2265765A1 (en)
DE (2) DE19637043A1 (en)
TR (1) TR199901200T2 (en)
WO (1) WO1998011082A1 (en)
ZA (1) ZA978170B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0108876D0 (en) * 2001-04-09 2001-05-30 Novartis Ag Organic Compounds
US8673931B2 (en) * 2009-01-26 2014-03-18 Abraham Fisher Bicyclic heterocyclic spiro compounds
AU2016281685B2 (en) 2015-06-24 2021-08-12 Nitto Denko Corporation Ionizable compounds and compositions and uses thereof
US10800635B2 (en) 2017-08-30 2020-10-13 Otis Elevator Company Elevator door wedge monitoring system
CA3178455A1 (en) 2020-04-09 2021-10-14 Suzhou Abogen Biosciences Co., Ltd. Lipid nanoparticle composition
WO2021204179A1 (en) 2020-04-09 2021-10-14 Suzhou Abogen Biosciences Co., Ltd. Nucleic acid vaccines for coronavirus

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3689494A (en) * 1971-03-31 1972-09-05 William R J Simpson N-pyridinealkyl-alkanolamine nitrates
US4158093A (en) * 1977-12-15 1979-06-12 Reilly Tar & Chemical Corporation Process for substituting and dequaternizing pyridylethyl quaternary salts of pyridine and bypyridine bases
JPS6325654A (en) * 1986-07-18 1988-02-03 Fuji Photo Film Co Ltd Color photographic developing solution composition and method for processing silver halide color photographic sensitive material
JPH05232660A (en) * 1992-02-19 1993-09-10 Konica Corp Treatment for silver halide color photographic sensitive material
JP2588339B2 (en) * 1992-06-02 1997-03-05 花王株式会社 Novel diamino diester and method for producing the same
US5334761A (en) * 1992-08-28 1994-08-02 Life Technologies, Inc. Cationic lipids
JPH06340598A (en) * 1993-05-28 1994-12-13 Lion Corp New diester diamine compound, intermediate therefor and its production and softening agent
US5491263A (en) * 1993-12-21 1996-02-13 The Dow Chemical Company Aminoethylation process for production of substituted ethylene diamines
FR2717694B1 (en) * 1994-03-22 1996-05-03 Seppic Sa A composition comprising a recombinant plasmid and its uses as a vaccine and medicament.
FR2727679B1 (en) * 1994-12-05 1997-01-03 Rhone Poulenc Rorer Sa NEW TRANSFECTION AGENTS AND THEIR PHARMACEUTICAL APPLICATIONS
US5635487A (en) * 1994-12-29 1997-06-03 Wolff; Jon A. Amphipathic, micellar delivery systems for biologically active polyions
DE19521412A1 (en) * 1995-06-14 1996-12-19 Boehringer Mannheim Gmbh New cationic and polycationic amphiphiles, reagents containing them and their use

Also Published As

Publication number Publication date
KR20000036063A (en) 2000-06-26
AU4384197A (en) 1998-04-02
BR9712818A (en) 1999-12-21
JP4191251B2 (en) 2008-12-03
WO1998011082A1 (en) 1998-03-19
EP0927174A1 (en) 1999-07-07
CA2265765A1 (en) 1998-03-19
JP2001504806A (en) 2001-04-10
AU741636B2 (en) 2001-12-06
TR199901200T2 (en) 1999-10-21
CN1237161A (en) 1999-12-01
ATE380798T1 (en) 2007-12-15
CN1087293C (en) 2002-07-10
DE59712902D1 (en) 2008-01-24
EP0927174B1 (en) 2007-12-12
DE19637043A1 (en) 1998-03-19

Similar Documents

Publication Publication Date Title
AU649849B2 (en) New vanadium complexes, process for preparing them and pharmaceutical compositions containing them
MX9604020A (en) Arylalkyldiazinones.
HU9602966D0 (en) Acylated aminophenylsulphonylureas, process for their preparation and their use as herbicides and plant-growth regulators
KR940002942B1 (en) Process for preparing antimycotic nail varnish
GB2346879A (en) Preparation of 3-substituted adenines and imidazo pyridines
GB0013737D0 (en) Novel compounds
YU22000A (en) Byciclic kinase inhibitors
MX9600686A (en) Substituted azaindolylidene compounds and process for their preparation.
EP0691327A4 (en) Amine derivative and dermatologic preparation containing the same
MX9803761A (en) Lipopolyamines as transfection agents and pharmaceutical uses thereof.
AP9701041A0 (en) Pyridylpyrrole compounds.
CA2212326A1 (en) O-carbamoyl-(d)-phenylalanilol compounds and process for preparing the same
MX9606331A (en) Novel compound, process for producing the same, and antitumor agent.
MD970313A (en) New cryptophycines prepared by means of synthesis
BG100661A (en) Aryl acetic acid derivatives
ZA978170B (en) Novel amino alcohol derivatives process for their manufacture and medical preparations containing these compounds
ES8702888A1 (en) Adamantan amine derivatives, process for their preparation and medicines containing them.
UA41871C2 (en) Derivatives of erythromycin, a process for the preparation thereof and a pharmaceutical composition based thereon
UA35556C2 (en) process for the preparation of hydrocortisone AND INTERMEDIATE compounds in the synthesis of hydrocortisone
ES476645A1 (en) Amino derivatives of pyrazolo [1,5-a]s-triazine, and their therapeutic applications
AP1518A (en) Novel octahydro-6, 10-dioxo-6h-pyridazino/1,2-a/ /1,2/diazepin-1-carboxylic acid derivatives, preparation method and use for preparing therapeutically active compounds.
YU25699A (en) Novel erythromycin derivatives, method for preparing them and their use
GR1003725B (en) Bifunctional agents possessing antioxidant and antiarrhythmic activity
MX9605400A (en) Novel tetrapeptides, their manufacture and use.
EP0369398A3 (en) Polyphosphazene derivatives containing carbonyl groups suitable for photoreticulation processes